Fig. 1
From: Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients
Time course for eGFR changes for the patient population. Mean ± standard deviation baseline eGFR for all 40 patients was 73.9 ± 18.1 mL/min/1.73 m2. A mild decrease in eGFR is seen over time. Mean eGFR at 12, 24, 36, 48, and 60 months was 70.6 ± 20.9, 66.6 ± 20.5, 61.4 ± 19.3, 59.5 ± 15.7, and 81.3 ± 28.5 mL/min/1.73 m2, respectively. *: Time point showing a significant difference compared to baseline eGFR